Has anybody found the THERMISOL FREE H1N1 vaccine?

[Anonymous]

If so, please share where you got it. I've gone to two clinics and while they have the regular vaccine, they have not yet gotten their thermisol free version (which is also the version for kids 2 and under).

thanks so much!

[Anonymous]

Please see this post -- I called the CDC this morning, and they said they might not be getting it at all (contrary to what their web site says).

http://www.dcurbanmom.com/jforum/posts/list/74953.page

[Anonymous]

No one has the thimerosal-free H1N1 shot yet. Some of the shots (single dose ones by Novartis) have only a trace amount, but that's it.

[Anonymous]

Do you know who has the Novartis one (vs. the other manufacturers)?

[Anonymous]

The DC clinic at Cardozo last night had the Novartis single-dose shot with a trace of thimerosal and I received one (pregnant).

[Anonymous]

How do you know which brand of shot you're getting? Do they tell you? Do you have to ask?

[Anonymous]

Just ask -- I did this for the regular flu shot. You're the patient; you have the right to know.

[Anonymous]

My copy of the MoCo consent form lists the brand I got (Sanofi Pasteur) and dose - the nurse fills this in (along with batch # and injection site) after administering the vaccine because it's part of their required record-keeping. However, the form doesn't specify if the dose came from a single-dose vial, multi-use vial, or single-dose syringe - but I would assume it was a multi-dose vial.

[Anonymous]

12:58 poster again here. At DC they give you an immunization record form. It lists the manufacturer, doseage, and lot of the shot.

You can tell if it is a single-dose or multi-dose vial by how they are preparing it before they give it to you (single dose is one dose packaged separately so they will unwrap it to give it to you, rather than drawing up into a syringe from a vial).

Flu.gov has a page listing the specific ingredients of each of the available vaccines: http://answers.flu.gov/questions/4801 If the link doesn't work, it is under their FAQs section in answer to the question, "What are the specific ingredients in each of the 2009 H1N1 vaccines?"

CSL Influenza A (H1N1) 2009 Monovalent Vaccine (Shot)

Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg HA per 0.5 mL dose of influenza A/California/7/2009 (H1N1)v-like virus.

The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.

A single 0.5 mL dose of Influenza A (H1N1) 2009 Monovalent Vaccine contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate (? 10 ppm), ovalbumin (? 1 mcg), neomycin sulfate (? 0.2 picograms [pg]), polymyxin B (? 0.03 pg), and beta-propiolactone (< 25 nanograms).

The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.

For detailed information, see CSL Influenza A (H1N1) 2009 Monovalent Vaccine Patient Information (PDF-20 pages).


Novartis Vaccines & Diagnostics Limited 2009 Monovalent Vaccine (Shot)

Influenza A (H1N1) 2009 Monovalent Vaccine is a homogenized, sterile, slightly opalescent suspension in a phosphate buffered saline. Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg hemagglutinin (HA) per 0.5-mL dose of the following virus strain: A/California/7/2009 (H1N1)v-like virus.

The 0.5-mL prefilled syringe presentation is formulated without preservative. Thimerosal, a mercury derivative used during manufacturing, is removed by subsequent purification steps to a trace amount (? 1 mcg mercury per 0.5-mL dose).

The 5-mL multidose vial formulation contains thimerosal, a mercury derivative, added as a preservative. Each 0.5-mL dose from the multidose vial contains 25 mcg mercury.

Each dose from the multidose vial or from the prefilled syringe may also contain residual amounts of egg proteins (? 1 mcg ovalbumin), polymyxin (? 3.75 mcg), neomycin (? 2.5 mcg), betapropiolactone (not more than 0.5 mcg) and nonylphenol ethoxylate (not more than 0.015% w/v).

The multidose vial stopper and the syringe stopper/plunger do not contain latex.

For detailed information, see Novartis Vaccines & Diagnostics Limited 2009 Monovalent Vaccine Patient Information

Sanofi Pasteur 2009 Monovalent Vaccine (Shot)

Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg hemagglutinin (HA) of influenza A/California/07/2009 (H1N1) v-like virus per 0.5 mL dose. Gelatin 0.05% is added as a stabilizer. Each 0.5 mL dose may contain residual amounts of formaldehyde (not more than 100 mcg), polyethylene glycol p-isooctylphenyl ether (not more than 0.02%), and sucrose (not more than 2.0%).

There is no thimerosal used in the manufacturing process of the single-dose presentations of Influenza A (H1N1) 2009 Monovalent Vaccine. The multi-dose presentation of Influenza A (H1N1) 2009 Monovalent Vaccine contains thimerosal, a mercury derivative, added as a preservative. Each 0.5 mL dose of the multidose presentation contains 25 mcg mercury.

Antibiotics are not used in the manufacture of Influenza A (H1N1) 2009 Monovalent Vaccine.

All presentations of Influenza A (H1N1) 2009 Monovalent Vaccine do not contain latex.

For detailed information, see Sanofi Pasteur 2009 Monovalent Vaccine Patient Information (PDF-19 pages)


MedImmune 2009 Monovalent Vaccine (Spray)

Each pre-filled refrigerated Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal sprayer contains a single 0.2 mL dose. Each 0.2 mL dose contains 106.5-7.5 FFU of the live attenuated influenza virus reassortant of the pandemic (H1N1) 2009 virus: A/California/7/2009 (H1N1)v. Each 0.2 mL dose also contains 0.188 mg/dose monosodium glutamate, 2.00 mg/dose hydrolyzed porcine gelatin, 2.42 mg/dose arginine, 13.68 mg/dose sucrose, 2.26 mg/dose dibasic potassium phosphate, 0.96 mg/dose monobasic potassium phosphate, and <0.015 mcg/mL gentamicin sulfate. The vaccine contains no preservatives.

For detailed information, see MedImmune 2009 Monovalent Vaccine (Spray)Patient Information (PDF – 21 pages).

[Anonymous]

The DC clinic had a list of the different ones with ingredients & manufacturer. They fill out a card for you stating which one you got & you take the card with you. since they did not have the thimersol free one, i took the novartis one which, as a PP stated, only has a trace amount

[Anonymous]

To clarify, the critical difference is SINGLE-DOSE formulation versus MULTI-DOSE - all the brands have no or trace thimerosal in their single-dose formulations (see above ingredient listing).

[Anonymous]

You can also find a great listing of the manufacturers and ingredients at this site:


http://www.askdrsears.com/thevaccinebook/

[Anonymous]

I received a thimerisol free h1n1 at the DC's DOH

[Anonymous]

Anonymous wrote:I received a thimerisol free h1n1 at the DC's DOH

Are you certain? I called the CDC and they said there haven't been any thim-free vaxes shipped yet.

[Anonymous]

Anonymous wrote:

Anonymous wrote:I received a thimerisol free h1n1 at the DC's DOH

Are you certain? I called the CDC and they said there haven't been any thim-free vaxes shipped yet.

yes they showed me the box